| |
 |
|
Class Information
Number: 435/5
Name: Chemistry: molecular biology and microbiology > Measuring or testing process involving enzymes or micro-organisms; composition or test strip therefore; processes of forming such composition or test strip > Involving virus or bacteriophage
Description: Subject matter where the material to be measured or tested contains a virus or bacteriophage or the agent used for the measurement or test contains a virus or bacteriophage.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7507418 |
Adenovirus status as a predictor of body composition change, disease status, and treatment outcomes |
Mar. 24, 2009 |
| 7504365 |
Combinatorial artificial receptors including tether building blocks |
Mar. 17, 2009 |
| 7504364 |
Methods of making arrays and artificial receptors |
Mar. 17, 2009 |
| 7504224 |
Five-Helix protein |
Mar. 17, 2009 |
| 7504206 |
Postweaning multisystemic wasting syndrome and porcine circovirus from pigs |
Mar. 17, 2009 |
| 7504205 |
Uncharacterized ORF3 in SARS-coronavirus is a cyclic-AMP-dependent kinase and a target for SARS therapy |
Mar. 17, 2009 |
| 7504204 |
Detection of transmissible spongiform encephalopathy (TSE) protein employing a highly sensitive Western blot assay and chemiluminescent detection system |
Mar. 17, 2009 |
| 7501235 |
Methods of collecting and transporting vaginal discharge for detection of infectious organisms and to facilitate cervical cancer screening |
Mar. 10, 2009 |
| 7498130 |
Method of reducing viral load |
Mar. 3, 2009 |
| 7497997 |
Assay cartridges and methods of using the same |
Mar. 3, 2009 |
| 7494799 |
Paramunity inducers based on attenuated rabbit myxoma virus |
Feb. 24, 2009 |
| 7494769 |
Method and apparatus for detection of bioaerosols |
Feb. 24, 2009 |
| 7494768 |
Mutational profiles in HIV-1 protease and reverse transcriptase correlated with phenotypic drug resistance |
Feb. 24, 2009 |
| 7494767 |
Assay for TSG101 as inhibitors of HIV production |
Feb. 24, 2009 |
| 7491808 |
HCV non-structural protein mutants and uses thereof |
Feb. 17, 2009 |
| 7491490 |
Cytomegalovirus disintegrin-like peptides |
Feb. 17, 2009 |
| 7491489 |
Synthetic peptide targeting critical sites on the SARS-associated coronavirus spike protein responsible for viral infection and method of use thereof |
Feb. 17, 2009 |
| 7491387 |
Disinfection of foodstuffs |
Feb. 17, 2009 |
| 7488596 |
Microfluidic device comprising electrolysis device for cell lysis and method for electrochemically lysing cells using the same |
Feb. 10, 2009 |
| 7488593 |
Multifunctional biomaterials as scaffolds for electronic, optical, magnetic, semiconducting, and biotechnological applications |
Feb. 10, 2009 |
| 7485855 |
On-probe sample cleanup system and method for MALDI analysis |
Feb. 3, 2009 |
| 7485446 |
Stable retrovirus and methods of use |
Feb. 3, 2009 |
| 7485416 |
Screening methods for the identification of agents that inhibit SIRT1 Tat deacetylase activity |
Feb. 3, 2009 |
| 7485415 |
Sequence analysis of the tetravalent rotavirus vaccine |
Feb. 3, 2009 |
| 7485312 |
Surface protein (HBsAg) variant of the hepatitis B virus |
Feb. 3, 2009 |
| 7482150 |
Virulent systemic feline calicivirus |
Jan. 27, 2009 |
| 7482142 |
High-risk human papillomavirus detection |
Jan. 27, 2009 |
| 7482115 |
Immobilisation and stabilisation of virus |
Jan. 27, 2009 |
| 7479538 |
Irreversibly-inactivated pepsinogen fragment and pharmaceutical compositions comprising the same for detecting, preventing, and treating HIV |
Jan. 20, 2009 |
| 7479386 |
HXHV virus, nucleic material, peptide material and uses |
Jan. 20, 2009 |
| 7476656 |
Fluorescent affinity tag to enhance phosphoprotein detection and characterization |
Jan. 13, 2009 |
| 7476499 |
Methods of identifying anti-viral agents |
Jan. 13, 2009 |
| 7476498 |
Peptides derived from capsid antigens of the Epstein-Barr virus and the use thereof |
Jan. 13, 2009 |
| 7473773 |
Determination of hepatitis C virus genotype |
Jan. 6, 2009 |
| 7473551 |
Nano-mechanic microsensors and methods for detecting target analytes |
Jan. 6, 2009 |
| 7473524 |
Mutational profiles in HIV-1 protease correlated with phenotypic drug resistance |
Jan. 6, 2009 |
| 7473421 |
Humanized anti-CCR2 antibodies and methods of use therefor |
Jan. 6, 2009 |
| 7470506 |
Fitness assay and associated methods |
Dec. 30, 2008 |
| 7465538 |
Multiplex flow assays preferably with magnetic particles as solid phase |
Dec. 16, 2008 |
| 7465537 |
Compounds and methods for inhibiting hepatitis C virus replication |
Dec. 16, 2008 |
| 7465456 |
Multi plasmid system for the production of influenza virus |
Dec. 16, 2008 |
| 7462446 |
Magnetic nanoparticle compositions and methods |
Dec. 9, 2008 |
| 7461006 |
Method and system for the analysis and association of patient-specific and population-based genomic data with drug safety adverse event data |
Dec. 2, 2008 |
| 7459297 |
Active truncated form of the RNA polymerase of flavivirus |
Dec. 2, 2008 |
| 7459270 |
Modified Vaccinia Ankara virus variant |
Dec. 2, 2008 |
| 7459269 |
Detection of bovine viral diarrhea virus in hair samples |
Dec. 2, 2008 |
| 7459160 |
Chimeric flaviviruses |
Dec. 2, 2008 |
| 7455969 |
Highly permissive cell lines for hepatitis C virus RNA replication |
Nov. 25, 2008 |
| 7452730 |
DNA-binding polymers |
Nov. 18, 2008 |
| 7452664 |
Methods for identifying agents which alter histone protein acetylation |
Nov. 18, 2008 |
|
|
|
